{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:49:17Z","timestamp":1786470557602,"version":"build-2736575974"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>\n                    <jats:italic>Helicobacter pylori<\/jats:italic>\n                    is one of the most widespread pathogens in humans and a strong predictor of gastric cancers. This systematic review and meta-analysis (PROSPERO: CRD420261375391) aimed at determining the extent, clinical impact, and antibiotic resistance profile of\n                    <jats:italic>H. pylori<\/jats:italic>\n                    infections in Cameroon. Six databases were exploited to identify relevant studies published between 2000 and 2026, as per PRISMA guidelines. Pooled proportions were computed using random effects models, while sensitivity analyses were performed to identify confounding factors. A total of 46 studies were included. The pooled proportion of\n                    <jats:italic>H. pylori<\/jats:italic>\n                    infection was 56.7% (95%CI 51.1 \u2013 62.1%), with higher estimates found in i) clinical settings (57.0%), ii) the regions of Centre (62.2%) and Littoral (58.5%), iii) adults (59.7%), and individuals with gastrointestinal disorders (60.1%). The burden of\n                    <jats:italic>H. pylori<\/jats:italic>\n                    was positively correlated with gastric disease severity, with 64.5% of infection cases seen in gastric cancer. Infections have led to adverse clinical effects (e.g., anemia).\n                    <jats:italic>H. pylori<\/jats:italic>\n                    isolates were highly resistant to metronidazole (87.6%, 95%CI 62.4 \u2013 96.8%), while the lowest resistant rates were found for levofloxacin (1.1%, 95%CI 0.4 - 3.2%) and rifampicin (0.6%, 95%CI 0.1 - 2.2%). An unusually high resistance rate to amoxicillin (93.4%; 95% CI 85.9\u201397.0%) was observed, warranting confirmatory studies. Multidrug-resistant isolates accounted for 77.6%. Several urgent challenges, including the lack of studies in four regions, in other at-risk groups (e.g., obese), limited clinical data, and resistance status vis-\u00e0-vis other commonly prescribed ATBs (i.e., amoxicillin), have been identified. This comprehensive study provides baseline data to improve therapeutic management and resistance stewardship in Cameroon.\n                  <\/jats:p>","DOI":"10.1371\/journal.pgph.0006486","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:25:45Z","timestamp":1786469145000},"page":"e0006486","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Burden, clinical impact, and primary antimicrobial resistance profiles of Helicobacter pylori infections in Cameroon: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"6","author":[{"given":"Eliane V.","family":"Assokom Okoubalimba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith G. L. F.","family":"Ekwe Priso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idriss","family":"Ntatou Lemouchele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle C.","family":"Kedy Koum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin L.","family":"Koanga Mogtomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4286-147X","authenticated-orcid":true,"given":"Loick P.","family":"Kojom Foko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"issue":"1","key":"pgph.0006486.ref001","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-024-01654-2","article-title":"Helicobacter pylori and gastric cancer: mechanisms and new perspectives","volume":"18","author":"Y Duan","year":"2025","journal-title":"J Hematol Oncol"},{"key":"pgph.0006486.ref002","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/5584_2019_357","article-title":"Epidemiology, diagnosis and risk factors of Helicobacter pylori infection","volume":"1149","author":"K Kotilea","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"pgph.0006486.ref003","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis","volume":"153","author":"JKY Hooi","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"pgph.0006486.ref004","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022","volume":"166","author":"Y-C Chen","year":"2024","journal-title":"Gastroenterology"},{"issue":"9","key":"pgph.0006486.ref005","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1038\/s41591-025-03793-6","article-title":"Global lifetime estimates of expected and preventable gastric cancers across 185 countries","volume":"31","author":"JY Park","year":"2025","journal-title":"Nat Med"},{"key":"pgph.0006486.ref006","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1146\/annurev-med-042220-020814","article-title":"Diagnosis and treatment of Helicobacter pylori infection","volume":"73","author":"Y-C Lee","year":"2022","journal-title":"Annu Rev Med"},{"key":"pgph.0006486.ref007","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions","volume":"155","author":"A Savoldi","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"pgph.0006486.ref008","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1186\/s12916-024-03816-y","article-title":"Global prevalence of Helicobacter pylori antibiotic resistance among children in the world health organization regions between 2000 and 2023: a systematic review and meta-analysis","volume":"22","author":"A Salahi-Niri","year":"2024","journal-title":"BMC Med"},{"key":"pgph.0006486.ref009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.9734\/ajob\/2022\/v14i330219","article-title":"Epidemiological profile of gastrointestinal cancers in Douala, Littoral region of Cameroon: a hospital-based retrospective study, 2016 \u2013 2020","volume":"14","author":"JGLF Ekwe Priso","year":"2022","journal-title":"Asian J Biol"},{"issue":"3","key":"pgph.0006486.ref010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Z Munn","year":"2015","journal-title":"Int J Evid Based Healthc"},{"issue":"11","key":"pgph.0006486.ref011","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jech-2013-203104","article-title":"Meta-analysis of prevalence","volume":"67","author":"JJ Barendregt","year":"2013","journal-title":"J Epidemiol Community Health"},{"issue":"2","key":"pgph.0006486.ref012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229345","article-title":"A solution to minimum sample size for regressions","volume":"15","author":"DG Jenkins","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"pgph.0006486.ref013","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1186\/s12879-019-4536-8","article-title":"Broad spectrum resistance in Helicobacter pylori isolated from gastric biopsies of patients with dyspepsia in Cameroon and efflux-mediated multiresistance detection in MDR isolates","volume":"19","author":"LB Kouitcheu Mabeku","year":"2019","journal-title":"BMC Infect Dis"},{"key":"pgph.0006486.ref014","doi-asserted-by":"crossref","first-page":"63","DOI":"10.11648\/j.ijg.20200402.17","article-title":"Evolution of susceptibilities of Helicobacter pylori strains circulating in Cameroon to usual antibiotics: a three-year study","volume":"4","author":"B Eyoum Bille","year":"2020","journal-title":"Int J Gastroenterol"},{"issue":"6","key":"pgph.0006486.ref015","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1365-3156.2008.02062.x","article-title":"Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram","volume":"13","author":"RN Ndip","year":"2008","journal-title":"Trop Med Int Health"},{"issue":"10","key":"pgph.0006486.ref016","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1136\/gutjnl-2025-335523","article-title":"Helicobacter pylori antibiotic resistance: a global challenge in search of solutions","volume":"74","author":"C Schulz","year":"2025","journal-title":"Gut"},{"key":"pgph.0006486.ref017","article-title":"Prevalence of Helicobacter pylori infection in India: a systematic re-view and meta-analysis","author":"S Puzhakkal","year":"2025","journal-title":"Evid Synth Healthc Connect"},{"issue":"43","key":"pgph.0006486.ref018","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.3748\/wjg.v30.i43.4636","article-title":"Prevalence of Helicobacter pylori infection in China from 2014-2023: a systematic review and meta-analysis","volume":"30","author":"L Xie","year":"2024","journal-title":"World J Gastroenterol"},{"issue":"1","key":"pgph.0006486.ref019","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s42770-023-01190-0","article-title":"Prevalence and associated risk factors of Helicobacter pylori infection in East Africa: a systematic review and meta-analysis","volume":"55","author":"Z Mnichil","year":"2024","journal-title":"Braz J Microbiol"},{"issue":"3","key":"pgph.0006486.ref020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S2352-4642(21)00400-4","article-title":"The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis","volume":"6","author":"C Yuan","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"pgph.0006486.ref021","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1186\/s12879-026-12832-7","article-title":"Prevalence, risk factors, and endoscopic findings among individuals infected with Helicobacter pylori in Tanzania: a systematic review and meta-analysis","volume":"26","author":"H Jaka","year":"2026","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pgph.0006486.ref022","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10120-025-01677-9","article-title":"Burden of gastric cancer attributable to Helicobacter pylori in 27 countries from seven geographic regions in 2022","volume":"29","author":"G Collatuzzo","year":"2026","journal-title":"Gastric Cancer"},{"issue":"5","key":"pgph.0006486.ref023","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41575-025-01042-2","article-title":"Helicobacter pylori, microbiota and gastric cancer - principles of microorganism-driven carcinogenesis","volume":"22","author":"J Wizenty","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"pgph.0006486.ref024","doi-asserted-by":"crossref","first-page":"850389","DOI":"10.3389\/fonc.2022.850389","article-title":"Prevalence of Helicobacter pylori in Non-Cardia gastric cancer in China: a systematic review and meta-analysis","volume":"12","author":"Y Lu","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"pgph.0006486.ref025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12879-024-10427-8","article-title":"The association of Helicobacter pylori infection with the risk of anemia in children: systematic review and meta-analysis","volume":"25","author":"M Walle","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"5","key":"pgph.0006486.ref026","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/trstmh\/trad089","article-title":"Knowledge and approach towards Helicobacter pylori diagnosis and management among primary care physicians in Cameroon: a cross-sectional study","volume":"118","author":"N Tazinkeng","year":"2024","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"pgph.0006486.ref027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.15403\/jgld-6725","article-title":"Long-term effect of Helicobacter pylori eradication on risk factors for cardiovascular disease - is there a connection?","volume":"35","author":"K Tepes","year":"2026","journal-title":"J Gastrointestin Liver Dis"},{"issue":"4","key":"pgph.0006486.ref028","doi-asserted-by":"crossref","first-page":"102804","DOI":"10.1016\/j.clinre.2026.102804","article-title":"Association between Helicobacter pylori infection and dyslipidemia: evidence from observational studies and Mendelian randomization analysis","volume":"50","author":"F Ren","year":"2026","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"38","key":"pgph.0006486.ref029","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000044583","article-title":"High prevalence of overweight and obesity among young adults, Cameroon","volume":"104","author":"AF Moguem Soubgui","year":"2025","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"pgph.0006486.ref030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12879-019-3677-0","article-title":"Helicobacter pylori infection among patients presenting with dyspepsia at a primary care setting in Cameroon: seroprevalence, five-year trend and predictors","volume":"19","author":"JA Aminde","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"2","key":"pgph.0006486.ref031","doi-asserted-by":"crossref","first-page":"49","DOI":"10.34172\/ajcmi.2019.10","article-title":"Etiologic profile and sensitivity pattern of germs responsible for urinary tract infection among under-five children in douala, cameroon: a hospital-based study","volume":"6","author":"DFK Motse","year":"2019","journal-title":"Avicenna J Clin Microbiol Infect"},{"key":"pgph.0006486.ref032","first-page":"1","article-title":"Knowledge and beliefs towards malaria and associated factors among residents of the town of Douala, Cameroon","volume":"14","author":"LP Kojom Foko","year":"2018","journal-title":"Arch Curr Res Int"},{"issue":"10","key":"pgph.0006486.ref033","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2468-1253(17)30219-4","article-title":"Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis","volume":"2","author":"Y-T Kuo","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"pgph.0006486.ref034","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2468-1253(23)00281-9","article-title":"Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis","volume":"9","author":"T-C Hong","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"pgph.0006486.ref035","article-title":"Global primary antibiotic resistance rate of Helicobacter pylori in recent 10\u2009years: a systematic review and meta-analysis","volume":"29","author":"Y Yu","year":"2024","journal-title":"Helicobacter"},{"issue":"9","key":"pgph.0006486.ref036","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.71238","article-title":"Global profile of drug resistance related to Helicobacter pylori infection in children: a systematic review and meta-analysis","volume":"8","author":"S Menbari","year":"2025","journal-title":"Health Sci Rep"},{"key":"pgph.0006486.ref037","doi-asserted-by":"crossref","first-page":"1481763","DOI":"10.3389\/fmicb.2024.1481763","article-title":"Insights into Helicobacter pylori macrolide resistance: a comprehensive systematic review and meta-analysis","volume":"15","author":"S Morad Kasani","year":"2024","journal-title":"Front Microbiol"},{"issue":"1","key":"pgph.0006486.ref038","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlaf235","article-title":"A systematic review of antimicrobial stewardship practices and challenges in sub-Sahara Africa (SSA) regulated retail medicine settings","volume":"8","author":"AG Orisile","year":"2026","journal-title":"JAC Antimicrob Resist"},{"issue":"1","key":"pgph.0006486.ref039","doi-asserted-by":"crossref","first-page":"101217","DOI":"10.1016\/j.lanmic.2025.101217","article-title":"Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study","volume":"7","author":"HpGP Research Network","year":"2026","journal-title":"Lancet Microbe"},{"issue":"9","key":"pgph.0006486.ref040","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3390\/antibiotics10091061","article-title":"The emergence of multidrug-resistant Helicobacter pylori in Southeast Asia: a systematic review on the trends and intervention strategies using antimicrobial peptides","volume":"10","author":"A Sukri","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"pgph.0006486.ref041","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.arcmed.2022.08.010","article-title":"Prevalence of primary multidrug-resistant Helicobacter pylori in children: a systematic review and meta-analysis","volume":"53","author":"M Karbalaei","year":"2022","journal-title":"Arch Med Res"},{"issue":"1","key":"pgph.0006486.ref042","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12879-018-3099-4","article-title":"The magnitude of antibiotic resistance to Helicobacter pylori in Africa and identified mutations which confer resistance to antibiotics: systematic review and meta-analysis","volume":"18","author":"H Jaka","year":"2018","journal-title":"BMC Infect Dis"},{"key":"pgph.0006486.ref043","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13756-019-0632-1","article-title":"Characteristics of Helicobacter pylori antibiotic resistance: data from four different populations","volume":"8","author":"D-S Liu","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"pgph.0006486.ref044","doi-asserted-by":"crossref","first-page":"108479","DOI":"10.1016\/j.micpath.2026.108479","article-title":"Mutation-driven mechanisms underlying antibiotic resistance of Helicobacter pylori in Asia: a systematic review and meta-analysis (2000-2024)","volume":"216","author":"S Dutta","year":"2026","journal-title":"Microb Pathog"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0006486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:25:54Z","timestamp":1786469154000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0006486"}},"subtitle":[],"editor":[{"given":"Kiatichai","family":"Faksri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0006486","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}